Erin X. Wei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Erin X. Wei has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
Divya Sharma
Department of Dermatology, University of Nebraska Medical Center, Omaha, USA
15 shared publicationsMitchell A. Taylor
Advocate Health Care, Preliminary Medicine Year, Chicago, IL
14 shared publicationsSierra Thomas
University of Utah School of Medicine, Salt Lake City, USA
8 shared publicationsBianca E. Ituarte
University of Missouri-Kansas City School of Medicine, Kansas City, USA
7 shared publicationsBianca Ituarte
School of Medicine, University of Missouri-Kansas City, Kansas City, Missouri
6 shared publicationsChristopher Reagen
School of Medicine University of Missouri‐Kansas City Kansas City Missouri USA
6 shared publications
Latest Publications
- 17 September 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 424
Environmental associations of hidradenitis suppurativa: a single center analysis
- 17 September 2026
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 318 (1) , 424
Environmental associations of hidradenitis suppurativa: a single center analysis
- 29 April 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (3) , 763-765
Rural-urban disparities in melanoma management: A SEER database analysis of wide local excision vs Mohs surgery utilization and disease-specific outcomes
- 29 April 2026
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 95 (3) , 763-765
Rural-urban disparities in melanoma management: A SEER database analysis of wide local excision vs Mohs surgery utilization and disease-specific outcomes
- Open Access
- 2 March 2026
- Published by Dermsquared in Dermatology Online Journal
- Vol. 32 (1)
How we do it: Untangling the web of inpatient biopsy supplies from ambulatory clinics
- 2 March 2026
- Published by Dermsquared in Dermatology Online Journal
- Vol. 32 (1)
Open AccessHow we do it: Untangling the web of inpatient biopsy supplies from ambulatory clinics
- 11 October 2025
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 94 (2) , 666-669
A cross-sectional analysis of funding sources of dermatologic clinical trials
- 11 October 2025
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 94 (2) , 666-669
A cross-sectional analysis of funding sources of dermatologic clinical trials
- Open Access
- 12 September 2025
- Published by Lahey Hospital & Medical Center in The Lahey Journal
- Vol. 3 (1) , 1
Practice patterns in the management of pemphigus – An international survey study
Introduction: Anti-CD20 therapy (rituximab) has emerged as an effective and disease modifying treatment for pemphigus, especially in early disease. However, significant variability exists around the clinical application of this therapy. Methods: In this survey-based study among bullous disease experts, we investigated practice patterns surrounding the use of rituximab in the management of pemphigus. Anonymized surveys were sent to physician members of the internation Pemphigus and Pemphigoid Foundation. Topics of inquiry included the use of rituximab first line in newly diagnosed pemphigus, rituximab dosing regimen, use of concomitant steroid sparing agents, criteria for retreatment, and the use of antimicrobial prophylaxis. Results: Among specialists who responded to the survey, there was a strong consensus in the utilization of rheumatoid arthritis rituximab dosing regimen. There was variability in the thresholds for re-treatment with rituximab for patients in clinical remission and in the use prophylaxis for opportunistic infections. Additionally, there was a high level of dispersion in responses related to the use of concomitant immunosuppressive medications as well as the clinical and serologic markers used to monitor patients after treatment. Conclusion: This study provides valuable insight into real-world practice patterns in the treatment of pemphigus. While rituximab is being increasingly utilized as first line therapy in the management of pemphigus, there is a high degree of variability in its application, particularly with regards to retreatment parameters following clinical remission as well as in the use of antimicrobial prophylaxis. Further clinical data will be needed to establish best practices and consensus-based guidelines for the use of CD20 depleting therapy in pemphigus.
- 12 September 2025
- Published by Lahey Hospital & Medical Center in The Lahey Journal
- Vol. 3 (1) , 1
Open AccessPractice patterns in the management of pemphigus – An international survey study
Introduction: Anti-CD20 therapy (rituximab) has emerged as an effective and disease modifying treatment for pemphigus, especially in early disease. However, significant variability exists around the clinical application of this therapy. Methods: In this survey-based study among bullous disease experts, we investigated practice patterns surrounding the use of rituximab in the management of pemphigus. Anonymized surveys were sent to physician members of the internation Pemphigus and Pemphigoid Foundation. Topics of inquiry included the use of rituximab first line in newly diagnosed pemphigus, rituximab dosing regimen, use of concomitant steroid sparing agents, criteria for retreatment, and the use of antimicrobial prophylaxis. Results: Among specialists who responded to the survey, there was a strong consensus in the utilization of rheumatoid arthritis rituximab dosing regimen. There was variability in the thresholds for re-treatment with rituximab for patients in clinical remission and in the use prophylaxis for opportunistic infections. Additionally, there was a high level of dispersion in responses related to the use of concomitant immunosuppressive medications as well as the clinical and serologic markers used to monitor patients after treatment. Conclusion: This study provides valuable insight into real-world practice patterns in the treatment of pemphigus. While rituximab is being increasingly utilized as first line therapy in the management of pemphigus, there is a high degree of variability in its application, particularly with regards to retreatment parameters following clinical remission as well as in the use of antimicrobial prophylaxis. Further clinical data will be needed to establish best practices and consensus-based guidelines for the use of CD20 depleting therapy in pemphigus.
- 20 August 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Association of marital status with disease stage at presentation and disease-specific outcomes in cutaneous head and neck melanoma patients
- 20 August 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Association of marital status with disease stage at presentation and disease-specific outcomes in cutaneous head and neck melanoma patients
- 13 August 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (1) , 95-97
Trends in Pediatric Representation Within Skin of Color Dermatology Literature: A Decade‐Long Analysis
Recent initiatives have aimed to improve representation of skin of color (SOC) in dermatology texts, but studies assessing SOC representation in peer‐reviewed dermatology publications are adult focused. This study analyzes pediatric representation in SOC dermatologic literature from 2013 to 2023, revealing that although pediatric dermatology comprises a smaller share of the overall literature, it consistently demonstrates a higher proportional focus on SOC topics compared to adult dermatology. This sustained commitment underscores pediatric dermatology's leadership in advancing diversity and sets an important precedent for the field.
- 13 August 2025
- Published by Wiley in Pediatric Dermatology
- Vol. 43 (1) , 95-97
Trends in Pediatric Representation Within Skin of Color Dermatology Literature: A Decade‐Long Analysis
Recent initiatives have aimed to improve representation of skin of color (SOC) in dermatology texts, but studies assessing SOC representation in peer‐reviewed dermatology publications are adult focused. This study analyzes pediatric representation in SOC dermatologic literature from 2013 to 2023, revealing that although pediatric dermatology comprises a smaller share of the overall literature, it consistently demonstrates a higher proportional focus on SOC topics compared to adult dermatology. This sustained commitment underscores pediatric dermatology's leadership in advancing diversity and sets an important precedent for the field.
- 11 August 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (3) , 610-613
Patient Preferences for Physician‐Patient Demographic Concordance in Dermatology: A Cross‐Sectional Survey Study
- 11 August 2025
- Published by Wiley in International Journal of Dermatology
- Vol. 65 (3) , 610-613
Patient Preferences for Physician‐Patient Demographic Concordance in Dermatology: A Cross‐Sectional Survey Study
- 2 August 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-2
Demographics, education, and training background for dermatology department chairs and residency program directors
- 2 August 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-2
Demographics, education, and training background for dermatology department chairs and residency program directors
- 25 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Decreased physical activity in lupus patients, an analysis of biometric data from the all of us database
- 25 April 2025
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Decreased physical activity in lupus patients, an analysis of biometric data from the all of us database